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 Conclusions: The QVH tool provided a method to assess how well the 
prescription dose to target volumes was met in the treatment plans of 
this study. The tool could be used to identify a single suboptimal plan 
and to compare groups of plans which cannot be distinguished by 
means of the one-dimensional QF value. The QVH tool could, for 
example, be used in the quality assurance of a multi-centre trial, and 
for visualizing the learning curve of multiple dose level treatment 
planning in routine clinical practice. It could provide a valuable 
contribution to level 3 reporting of ICRU report 83. 
1 Duprez et al. IJROBP 2011 
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Purpose/Objective: Recently, a Cyberknife (CK) with an MLC became 
available. A key CK feature is easy delivery of non-coplanar (n-CP) 
beams. Objective evidence for added value of such beams is mostly 
lacking, partly because a common TPS for both systems did not exist 
until recently. Moreover, commercial TPS require trial-and-error 
tweaking of plan parameters for individual patients, making the 
outcome of planning highly user-dependent. With the recent MLC 
introduction, our in-house algorithm for multi-criterial plan 
optimization, iCycle, can now also optimize IMRT for CK. With iCycle, 
plan generation is fully automatic (no per patient tweaking), allowing 
objective comparison of treatment strategies in a single TPS. In this 
study we used iCycle to compare n-CP CK and CP linac approaches for 
prostate cancer. 
Materials and Methods: For 10 patients, iCycle was used to 
automatically generate plans with optimized profiles and beam angles 
for the CK and a conventional linac, emulating HDR brachytherapy 
dosimetry. For the linac, the beam search space contained 72 
coplanar orientations (separation 5°). For both systems, Pareto 
optimal IMRT plans were automatically generated, containing 1-30 
optimized beam directions (60 plans per patient), delivering 4 
fractions of 9.5Gy. Low rectum dose was the highest priority OAR 
objective for generating optimal plans within hard constraints, 
following achievement of a PTV V95 of ±99%.Other OARs considered 
were urethra, bladder, penis, scrotum, and femoral heads. 
Results: Both for the CK and the linac, PTV V95 was >99%. For both 
systems, plan quality did heavily depend on the number of beams 
included in the plan. For CK, rectum Dmean, V40Gy, V60Gy, and D1cc in 25 
beam plans were on average 50%, 67%, 71% and 15% lower than in 11 
beam plans, for equal PTV coverage. For 25 beam plans, differences 
between CK and linac in PTV- and peripheral zone Dmean and D98% were 
on average smaller than 0.3% (p>0.05), while the CK plans had 
18.5±8.0%, 23.2±14.1%, 21.4±20.8%, and 3.0±3.8% lower rectum Dmean, 
V40Gy, V60Gy, and D1cc, respectively (p=0.002; for all 10 patients, all 4 
rectum parameters were lowest for CK). There were no differences in 
urethra Dmean and D2% and in bladder Dmean. Bladder D2% was 2.5% lower 
for CK (p=0.002). For the femoral heads, Dmean and D2% were 20% and 
10% lower in CK plans (p=0.002). In all plans, penis/scrotum Dmean and 
D2% were lower than 2Gy and 4Gy, respectively, as imposed by hard 
constraints. Delivery time of 25 beam CK plans was 18.1±0.5 min, 
including imaging and correction for each beam.  
Conclusions: Non-coplanar hypo-fractionated treatment of prostate 
cancer with a Cyberknife did strongly reduce rectum dose compared 
to coplanar linac plans. For both systems, 25 beam plans greatly 
improved rectum dose compared to 11 beam plans. Due to the MLC, 
25 beam CK non-coplanar plans could be delivered in only 18 minutes, 
including image-guided beam-tumour alignment before delivery of 
each beam. 
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Purpose/Objective: The PARSPORT trial (CRUK/03/005) demonstrated 
that parotid-sparing intensity-modulated radiotherapy (IMRT) achieved 
a significant reduction in severe xerostomia compared with 
conventional radiotherapy in patients being treated for squamous cell 
carcinoma of the head and neck. An unexpected result of the trial was 
a significantly higher incidence of acute fatigue in patients 
randomised to receive IMRT. Analysis of trial data has shown that this 
correlates with increased radiation doses to central nervous system 
(CNS) structures. Based on this analysis potentially valuable dose-
volume constraints were implemented as inverse treatment planning 
objectives to explore the ability to reduce the dose to CNS structures 
without compromising the dose distributions to the tumour and 
normal tissues. 
Materials and Methods: A retrospective planning study was performed 
for 9 local patients – 3 each with tumours of the hypopharynx, 
oropharynx and nasopharynx. Relevant additional CNS structures were 
delineated by an experienced radiation oncologist. A 7-field inverse 
planned IMRT technique was used to produce clinically acceptable 
plans. Maximum dose-volume objectives were then introduced for the 
brainstem and cerebellum, the plans re-optimised and the level of 
cerebellum and brainstem dose-sparing assessed. The effect of the 
primary disease site on the ability to meet the constraints was 
investigated. 3D dose analysis was performed to assess the differences 
in the dose-distributions in other regions upon introduction of the 
constraints. 
Results: Introducing the additional CNS constraints into the treatment 
plan optimisation allowed significant dose-sparing to the cerebellum 
and brainstem to be achieved without compromising clinical plan 
assessment measures. Figure 1 shows the percentage improvement in 
the dose-volume statistics of interest when the CNS objectives were 
introduced. 
 
 
Figure 1: Percentage improvement in dose-volume statistics for the 
CNS structures upon introducing the CNS objectives. The white values 
indicate where the proposed constraints were achieved. For Hyp – 2 
the CNS constraints were already achieved prior to introducing the 
additional objectives into the plan optimisation. Many, but not all, of 
the CNS constraints could be achieved for most patients. Fewer 
constraints could be achieved for nasopharyngeal primaries compared 
with oropharyngeal and hypopharyngeal cancers. 3D dose analysis 
indicated that the dose reduction to the CNS structures resulted in 
consistent patterns of increased doses to uncontoured regions in the 
neck. 
Conclusions: It has been demonstrated that it is feasible to 
implement constraints to reduce the dose-distribution to the 
brainstem and cerebellum without compromising tumour coverage or 
sparing of organs at risk. However, the increased doses delivered to 
the neck should be carefully considered when assessing the dose-
distributions of plans produced using this technique. 
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